Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 850 shares at $171.38 ($146K) on 2023-08-29, disclosed to the SEC on 2023-08-30.
Open-market sale of $146k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |
| RGEN | SELL | 2021-11-12 | $2.5M | — | Filing → |